uniQure (QURE) Accumulated Depreciation (2015 - 2025)
uniQure (QURE) posted quarterly Accumulated Depreciation of $43.7 million for Q4 2025, up 38.16% year-over-year from $31.7 million in Q4 2024, and up 38.16% quarter-over-quarter from $31.7 million in Q4 2024.
Analysis
uniQure (QURE) Accumulated Depreciation (2015 - 2025) Analysis & Trends
uniQure's Accumulated Depreciation history runs 11 years deep, the most recent figure standing at $43.7 million for Q4 2025.
- In Q4 2025, Accumulated Depreciation rose 38.16% year-over-year to $43.7 million; the TTM figure through Dec 2025 stood at $43.7 million (up 38.16% YoY), while the FY2025 annual figure was $43.7 million, up 38.16% from the prior year.
- Accumulated Depreciation for Q4 2025 stood at $43.7 million, up from $31.7 million in the prior quarter.
- The five-year high for Accumulated Depreciation was $55.7 million in Q4 2023, with the low at $31.7 million in Q4 2024.
- The 5-year median for Accumulated Depreciation is $43.7 million (2025), against an average of $42.4 million.
- The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation sank 43.14% in 2024, then surged 38.16% in 2025.
- uniQure's Accumulated Depreciation stood at $36.9 million in 2021, then advanced by 19.58% to $44.1 million in 2022, then grew by 26.17% to $55.7 million in 2023, then tumbled by 43.14% to $31.7 million in 2024, then soared by 38.16% to $43.7 million in 2025.
- Business Quant data shows QURE's Accumulated Depreciation at $43.7 million in Q4 2025, $31.7 million in Q4 2024, and $55.7 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 43.74 Mn |
| Dec 31, 2024 | 31.66 Mn |
| Dec 31, 2023 | 55.67 Mn |
| Dec 31, 2022 | 44.13 Mn |
| Dec 31, 2021 | 36.90 Mn |
| Dec 31, 2020 | 35.23 Mn |
| Dec 31, 2019 | 28.63 Mn |
| Dec 31, 2018 | 22.89 Mn |
| Sep 30, 2018 | 21.30 Mn |
| Jun 30, 2018 | 19.64 Mn |
| Mar 31, 2018 | 18.35 Mn |
| Dec 31, 2017 | 17.04 Mn |
| Sep 30, 2017 | 17.64 Mn |
| Jun 30, 2017 | 15.75 Mn |
| Mar 31, 2017 | 13.74 Mn |
| Dec 31, 2016 | 12.07 Mn |
| Dec 31, 2015 | 10.94 Mn |